financetom
Business
financetom
/
Business
/
Nucor Q1 Revenue Drops, Expects Q2 Earnings to Increase Sequentially
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nucor Q1 Revenue Drops, Expects Q2 Earnings to Increase Sequentially
May 25, 2025 8:22 PM

04:53 PM EDT, 04/28/2025 (MT Newswires) -- Nucor ( NUE ) reported Q1 adjusted earnings late Monday of $0.77 per diluted share. The company did not disclose any comparison adjusted results for the last year quarter

Four analysts polled by FactSet expected $0.69.

Net sales in the 13 weeks ended April 5 were $7.83 billion, compared with $8.14 billion in the first quarter of 2024. Analysts surveyed by FactSet expected $7.22 billion.

The company expects earnings in Q2 to increase compared with Q1 of 2025.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nvidia-backed CoreWeave to buy crypto miner Core Scientific in $9 billion deal
Nvidia-backed CoreWeave to buy crypto miner Core Scientific in $9 billion deal
Jul 7, 2025
(Reuters) -CoreWeave ( CRWV ) will buy crypto miner Core Scientific ( CORZ ) in an all-stock deal valued at about $9 billion, the company said on Monday, as AI infrastructure firms race to secure power supply to support their surging workloads. The acquisition highlights how artificial intelligence companies are moving beyond traditional data centers and looking to repurpose the...
CoreWeave to acquire crypto miner Core Scientific
CoreWeave to acquire crypto miner Core Scientific
Jul 7, 2025
July 7 (Reuters) - AI data center firm CoreWeave ( CRWV ) said on Monday it would buy crypto miner Core Scientific ( CORZ ) in an all-stock deal. (Reporting by Manya Saini in Bengaluru) ...
Cogent Biosciences Says Bezuclastinib Met Primary, Secondary Goals in Trial; Shares Rise
Cogent Biosciences Says Bezuclastinib Met Primary, Secondary Goals in Trial; Shares Rise
Jul 7, 2025
08:30 AM EDT, 07/07/2025 (MT Newswires) -- Cogent Biosciences ( COGT ) said Monday that a trial evaluating bezuclastinib in patients with non-advanced systemic mastocytosis achieved statistical significance across all primary and key secondary endpoints. Patients treated with bezuclastinib showed a superior mean change in total symptom score of -24.3 points versus -15.4 points for placebo at 24 weeks, the...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved